Makary’s FDA reforms ‘continue to move forward’ despite leadership turmoil
As the FDA adjusts to life without Marty Makary, M.D., who resigned as commissioner two weeks ago, the numerous policy reforms he put in motion remain intact, i...
As the FDA adjusts to life without Marty Makary, M.D., who resigned as commissioner two weeks ago, the numerous policy reforms he put in motion remain intact, including the controversial Commissioner’s National Priority Voucher (CNPV) program.